Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Hemophilia A"" wg kryterium: Temat


Starter badań:

Tytuł:
Pharmacokinetic parameter driven outcomes model predicts a reduction in bleeding events associated with BAY 81-8973 versus antihemophilic factor (recombinant) plasma/albumin-free method in a Chinese healthcare setting.
Autorzy:
Chen R; Hematology Department, Chengdu Third People's Hospital, Chengdu, China.
Gultyaev D; Certara USA, Inc, Lorrach, Germany.
Lister J; Formerly Certara USA, Inc, Lorrach, Germany.
Han R; Medical Affairs, Pharmaceuticals, Bayer Healthcare Company. Ltd, Beijing, China.
Hu N; Medical Affairs, Pharmaceuticals, Bayer Healthcare Company. Ltd, Beijing, China.
Malacan J; Global Market Access Hematology, Bayer Consumer Care AG, Peter Merian-Strasse 84, CH-4002, Basel, Switzerland. .
Solms A; Clinical Pharmacometrics, Bayer AG, Berlin, Germany.
Vashi P; Formerly at US Data Generation and Observational Studies, Bayer Corporation, Whippany, NJ, USA.
O'Hara J; HCD Economics, Daresbury, UK.
Hu S; School of Public Health, Fudan University, Shanghai, China.
Pokaż więcej
Źródło:
BMC medical research methodology [BMC Med Res Methodol] 2022 Aug 05; Vol. 22 (1), pp. 215. Date of Electronic Publication: 2022 Aug 05.
Typ publikacji:
Journal Article
MeSH Terms:
Factor VIII*/pharmacokinetics
Factor VIII*/therapeutic use
Hemophilia A*/complications
Hemophilia A*/drug therapy
Delivery of Health Care ; Hemorrhage/drug therapy ; Hemorrhage/prevention & control ; Humans ; Quality of Life ; Recombinant Proteins/adverse effects ; Recombinant Proteins/pharmacokinetics ; Serum Albumin/therapeutic use
Czasopismo naukowe
Tytuł:
[Acquired hemophilia and pregnancy: A necessarily multidisciplinary approach].
Autorzy:
Lévesque H; Service de médecine interne, Normandie université, UNIROUEN, Interne, 76031 Rouen, France. Electronic address: .
Guillet B; Centre de traitement des maladies hémorragiques, CHU de Rennes, Rennes, France; Inserm, EHESP, IRSET (institut de recherche en santé, environnement et travail) - UMR_S 1085, Université Rennes, CHU de Rennes, 35000 Rennes, France.
Benhamou Y; Service de médecine interne, Normandie université, UNIROUEN, Interne, 76031 Rouen, France.
Pokaż więcej
Transliterated Title:
Hémophilie acquise et grossesse : une approche forcément multidisciplinaire.
Źródło:
La Revue de medecine interne [Rev Med Interne] 2022 Aug; Vol. 43 (8), pp. 494-497. Date of Electronic Publication: 2022 May 27.
Typ publikacji:
Journal Article
MeSH Terms:
Hemophilia A*/diagnosis
Hemophilia A*/etiology
Hemophilia A*/therapy
Adrenal Cortex Hormones ; Factor VIII ; Female ; Humans ; Immunosuppressive Agents/therapeutic use ; Pregnancy
Czasopismo naukowe
Tytuł:
Multisystem inflammatory syndrome in a neonate with severe hemophilia - a diagnostic challenge in COVID times: a case report.
Autorzy:
Arun S; Department of Neonatology, Believers Church Medical College Hospital, Thiruvalla, Kerala, 689103, India. .
Cherian TG; Department of Neonatology, Believers Church Medical College Hospital, Thiruvalla, Kerala, 689103, India.
Philip C; Department of Hematology, Believers Church Medical College Hospital, Thiruvalla, Kerala, 689103, India.
Pokaż więcej
Źródło:
BMC pediatrics [BMC Pediatr] 2022 Jul 07; Vol. 22 (1), pp. 397. Date of Electronic Publication: 2022 Jul 07.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
COVID-19*
Hemophilia A*/complications
Hemophilia A*/diagnosis
Factor VIII ; Female ; Hematoma/complications ; Hematoma/etiology ; Hematoma, Subdural/diagnosis ; Hematoma, Subdural/etiology ; Humans ; Infant, Newborn ; Pregnancy ; Seizures/complications ; Systemic Inflammatory Response Syndrome/complications ; Systemic Inflammatory Response Syndrome/diagnosis
Czasopismo naukowe
Tytuł:
Acquired Hemophilia A in a Patient With Multiple Sclerosis.
Autorzy:
Sidarous GK; University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Roy AM; Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Sasapu A; Division of Hematology-Oncology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Pokaż więcej
Źródło:
The Permanente journal [Perm J] 2022 Jun 29; Vol. 26 (2), pp. 153-157. Date of Electronic Publication: 2022 Jun 15.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Hemophilia A*/complications
Hemophilia A*/drug therapy
Multiple Sclerosis*/complications
Aged ; Factor VIII/therapeutic use ; Female ; Hemorrhage ; Humans ; Male ; Middle Aged ; Partial Thromboplastin Time ; Pregnancy
SCR Disease Name:
Factor 8 deficiency, acquired
Czasopismo naukowe
Tytuł:
Hidden blood loss of total knee arthroplasty in hemophilia arthritis: an analysis of influencing factors.
Autorzy:
Shen SN; The First Clinical College of Zhejiang Chinese Medical University, The First Affiliated Hospital of Zhejiang Chinese Medical University, 548# BinWen Road, HangZhou, ZheJiang Province, People's Republic of China.
Wu DX; The First Clinical College of Zhejiang Chinese Medical University, The First Affiliated Hospital of Zhejiang Chinese Medical University, 548# BinWen Road, HangZhou, ZheJiang Province, People's Republic of China.
Lv SJ; The First Clinical College of Zhejiang Chinese Medical University, The First Affiliated Hospital of Zhejiang Chinese Medical University, 548# BinWen Road, HangZhou, ZheJiang Province, People's Republic of China.
Tong PJ; The First Clinical College of Zhejiang Chinese Medical University, The First Affiliated Hospital of Zhejiang Chinese Medical University, 548# BinWen Road, HangZhou, ZheJiang Province, People's Republic of China. .
Pokaż więcej
Źródło:
BMC musculoskeletal disorders [BMC Musculoskelet Disord] 2022 Jun 17; Vol. 23 (1), pp. 587. Date of Electronic Publication: 2022 Jun 17.
Typ publikacji:
Journal Article
MeSH Terms:
Antifibrinolytic Agents*/adverse effects
Arthritis*/etiology
Arthritis*/surgery
Arthroplasty, Replacement, Knee*/adverse effects
Hemophilia A*/complications
Hemophilia A*/drug therapy
Tranexamic Acid*/therapeutic use
Aged ; Blood Loss, Surgical/prevention & control ; Blood Transfusion ; Humans ; Postoperative Hemorrhage/prevention & control
Czasopismo naukowe
Tytuł:
Case Report: A Child With Hemophilia A Serves as Donor for Hematopoietic Stem Cell Transplantation to Cure His Brother's Severe Aplastic Anemia.
Autorzy:
Kertész G; Department of Pediatric Hematology and Stem Cell Transplantation, Central Hospital of Southern Pest, National Institute of Hematology and Infectious Diseases, Budapest, Hungary.
Kállay K; Department of Pediatric Hematology and Stem Cell Transplantation, Central Hospital of Southern Pest, National Institute of Hematology and Infectious Diseases, Budapest, Hungary.
Kassa C; Department of Pediatric Hematology and Stem Cell Transplantation, Central Hospital of Southern Pest, National Institute of Hematology and Infectious Diseases, Budapest, Hungary.; Department of Infectious Diseases, Semmelweis University, Budapest, Hungary.
Zombori M; Kemény Pál Pediatric Onco-Hematologic Department, Heim Pál National Pediatric Institute, Budapest, Hungary.
Bodó I; Department of Internal Medicine and Haematology, Semmelweis University, Budapest, Hungary.
Kiss C; Division of Pediatric Hematology-Oncology, Department of Pediatrics, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Szegedi I; Division of Pediatric Hematology-Oncology, Department of Pediatrics, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Kriván G; Department of Pediatric Hematology and Stem Cell Transplantation, Central Hospital of Southern Pest, National Institute of Hematology and Infectious Diseases, Budapest, Hungary.; Department of Infectious Diseases, Semmelweis University, Budapest, Hungary.
Pokaż więcej
Źródło:
Pathology oncology research : POR [Pathol Oncol Res] 2022 Jun 08; Vol. 28, pp. 1610171. Date of Electronic Publication: 2022 Jun 08 (Print Publication: 2022).
Typ publikacji:
Case Reports
MeSH Terms:
Anemia, Aplastic*/therapy
Graft vs Host Disease*
Hematopoietic Stem Cell Transplantation*
Hemophilia A*/complications
Hemophilia A*/therapy
Child ; Humans ; Male ; Siblings ; Transplantation Conditioning
Raport
Tytuł:
Risk factors for bleeding in people living with hemophilia A and B treated with regular prophylaxis: A systematic review of the literature.
Autorzy:
Germini F; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Noronha N; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.
Abraham Philip B; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.
Olasupo O; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.
Pete D; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.
Navarro T; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.
Keepanasseril A; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.
Matino D; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
de Wit K; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.; Department of Emergency Medicine, Queen's University, Kingston, Ontario, Canada.
Parpia S; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.; Department of Oncology, McMaster University, Hamilton, Ontario, Canada.
Iorio A; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Pokaż więcej
Źródło:
Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2022 Jun; Vol. 20 (6), pp. 1364-1375. Date of Electronic Publication: 2022 Apr 23.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Hemophilia A*/complications
Hemophilia A*/drug therapy
Europe ; Hemorrhage/chemically induced ; Humans ; Risk Factors ; Systematic Reviews as Topic
Czasopismo naukowe
Tytuł:
Hemophilia A developing cerebral infarction after surgical treatment of giant hemophilic pseudotumor: a case report.
Autorzy:
Ling Y; The First Affiliated Hospital of Zhejiang, Chinese Medical University, You Dian Road No.54, Hangzhou, 310006, Zhejiang Province, People's Republic of China.
Shi Z; The First Affiliated Hospital of Zhejiang, Chinese Medical University, You Dian Road No.54, Hangzhou, 310006, Zhejiang Province, People's Republic of China.
Su C; The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, Zhejiang, People's Republic of China.
Liu X; University of Toledo Medical Center, Toledo, OH, 43614, USA.
Zheng L; Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang, People's Republic of China.
Pan X; Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang, People's Republic of China.
Sun Y; Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang, People's Republic of China.
Zhang X; Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang, People's Republic of China.
Wei J; Tongde Hospital of Zhejiang Province, Hangzhou, 310007, Zhejiang, People's Republic of China.
Li J; The First Affiliated Hospital of Zhejiang, Chinese Medical University, You Dian Road No.54, Hangzhou, 310006, Zhejiang Province, People's Republic of China.
Tong P; The First Affiliated Hospital of Zhejiang, Chinese Medical University, You Dian Road No.54, Hangzhou, 310006, Zhejiang Province, People's Republic of China.
Xu T; The First Affiliated Hospital of Zhejiang, Chinese Medical University, You Dian Road No.54, Hangzhou, 310006, Zhejiang Province, People's Republic of China. .
Pokaż więcej
Źródło:
BMC surgery [BMC Surg] 2022 Aug 06; Vol. 22 (1), pp. 303. Date of Electronic Publication: 2022 Aug 06.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Hemophilia A*/complications
Adult ; Cerebral Infarction/etiology ; Cerebral Infarction/surgery ; Humans ; Magnetic Resonance Imaging ; Male ; Thigh
Czasopismo naukowe
Tytuł:
Postpartum-acquired hemophilia A: Experience from a tertiary center in South India.
Autorzy:
Vidyadharan G; Department of Pathology, Amrita Institute of Medical Sciences, Cochin, India.
Paul M; Department of Clinical Hematology, Rajagiri Hospital, Cochin, India.
Catherine Jacob A; Department of Pathology, Amrita Institute of Medical Sciences, Cochin, India.
Kurian B; Department of Pathology, Amrita Institute of Medical Sciences, Cochin, India.
Vijayakumar V; Department of Pathology, Amrita Institute of Medical Sciences, Cochin, India.
Sidharthan N; Department of Clinical Hematology, Amrita Institute of Medical Sciences, Cochin, India.
Unni M; Department of Clinical Hematology, Amrita Institute of Medical Sciences, Cochin, India.
Ganapathi R; Department of Clinical Hematology, Amrita Institute of Medical Sciences, Cochin, India.
Pokaż więcej
Źródło:
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics [Int J Gynaecol Obstet] 2022 Aug; Vol. 158 (2), pp. 483-484. Date of Electronic Publication: 2022 May 02.
Typ publikacji:
Journal Article
MeSH Terms:
Hemophilia A*/epidemiology
Hemophilia A*/therapy
Pregnancy Complications, Hematologic*
Factor VIII ; Female ; Humans ; India/epidemiology ; Postpartum Period ; Pregnancy
SCR Disease Name:
Factor 8 deficiency, acquired
Czasopismo naukowe
Tytuł:
Prevalence of cardiovascular diseases and risk factors in adult patients with haemophilia: a cross-sectional study in a tertiary care hospital clinic in Sri Lanka.
Autorzy:
Vithanage T; Haematology Unit, National Hospital of Sri Lanka, Colombo 10, Sri Lanka. .
Ratnamalala V; Haematology Unit, National Hospital of Sri Lanka, Colombo 10, Sri Lanka.
Wickramaratne C; Department of Pathology, Faculty of Medicine, University of Ruhuna, Galle, Sri Lanka.
Katulanda G; Chemical Pathology Unit, National Hospital of Sri Lanka, Colombo, Sri Lanka.
Rodrigo CH; Postgraduate Institute of Medicine, Colombo, Sri Lanka.
Pokaż więcej
Źródło:
BMC cardiovascular disorders [BMC Cardiovasc Disord] 2022 Jul 30; Vol. 22 (1), pp. 343. Date of Electronic Publication: 2022 Jul 30.
Typ publikacji:
Journal Article
MeSH Terms:
Cardiovascular Diseases*/diagnosis
Cardiovascular Diseases*/epidemiology
Cardiovascular Diseases*/etiology
Diabetes Mellitus*/epidemiology
Hemophilia A*/complications
Hemophilia A*/diagnosis
Hemophilia A*/epidemiology
Adult ; Body Mass Index ; Cholesterol ; Cholesterol, HDL ; Cross-Sectional Studies ; Humans ; Male ; Prevalence ; Risk Factors ; Sri Lanka/epidemiology ; Tertiary Care Centers ; Triglycerides
Czasopismo naukowe
Tytuł:
Total knee arthroplasty in patients with haemophilic arthropathy is effective and safe according to the outcomes at a mid-term follow-up.
Autorzy:
Wang R; Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Wang Z; Shi's Center of Orthopedics and Traumatology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.; Institute of Traumatology & Orthopedics, Shanghai Academy of Traditional Chinese Medicine, Shanghai, China.
Gu Y; Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Zhang J; Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Wang P; Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Tong P; The First Affiliated Hospital of Zhejiang, Chinese Medical University, 54 Youdian Road, Hangzhou, 310006, Zhejiang Province, China.
Lv S; The First Affiliated Hospital of Zhejiang, Chinese Medical University, 54 Youdian Road, Hangzhou, 310006, Zhejiang Province, China. .
Pokaż więcej
Źródło:
Journal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology [J Orthop Traumatol] 2022 Jul 11; Vol. 23 (1), pp. 31. Date of Electronic Publication: 2022 Jul 11.
Typ publikacji:
Journal Article
MeSH Terms:
Arthritis*/etiology
Arthroplasty, Replacement, Knee*/adverse effects
Contracture*/etiology
Hemophilia A*/complications
Hemophilia A*/surgery
Follow-Up Studies ; Humans ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł:
"A new hemophilia carrier nomenclature to define hemophilia in women and girls: Communication from the SSC of the ISTH": Comment.
Autorzy:
Bercovitz RS; Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.; Division of Hematology, Oncology, Neuro-Oncology, and Stem Cell Transplant, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
Pokaż więcej
Źródło:
Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2022 Jul; Vol. 20 (7), pp. 1744-1745.
Typ publikacji:
Letter
MeSH Terms:
Hemophilia A*/diagnosis
Hemophilia A*/genetics
Female ; Humans
Opinia redakcyjna
Tytuł:
Screening of behavioral disorders in children with hemophilia.
Autorzy:
Elsakka EE; Pediatrics Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Azouz HG; Pediatrics Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Hassab HA; Pediatrics Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Abdelfattah ME; Pediatrics Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Abdel Ghany HM; Physical Medicine, Rheumatology and Rehabilitation Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Pokaż więcej
Źródło:
International journal of rheumatic diseases [Int J Rheum Dis] 2022 Jul; Vol. 25 (7), pp. 803-810. Date of Electronic Publication: 2022 May 30.
Typ publikacji:
Journal Article
MeSH Terms:
Hemophilia A*/complications
Hemophilia A*/diagnosis
Hemophilia A*/epidemiology
Joint Diseases*
Mental Disorders*
Adolescent ; Child ; Humans ; Male
Czasopismo naukowe
Tytuł:
Diagnostic evaluation of the first macroscopic haematuria episode in adult haemophilia patients.
Autorzy:
Romano LGR; Department of Hematology, Hemophilia Treatment Center, Erasmus MC, Erasmus University Medical Center, Rotterdam, The Netherlands.
Mulders G; Department of Hematology, Hemophilia Treatment Center, Erasmus MC, Erasmus University Medical Center, Rotterdam, The Netherlands.
Stoof SCM; Department of Hematology, Hemophilia Treatment Center, Erasmus MC, Erasmus University Medical Center, Rotterdam, The Netherlands.
van Moort I; Department of Hematology, Hemophilia Treatment Center, Erasmus MC, Erasmus University Medical Center, Rotterdam, The Netherlands.
Busstra MB; Department of Urology, Erasmus MC, Erasmus University Medical Center, Rotterdam, The Netherlands.
Leebeek FWG; Department of Hematology, Hemophilia Treatment Center, Erasmus MC, Erasmus University Medical Center, Rotterdam, The Netherlands.
Kruip MJHA; Department of Hematology, Hemophilia Treatment Center, Erasmus MC, Erasmus University Medical Center, Rotterdam, The Netherlands.
Pokaż więcej
Źródło:
Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2022 Jul; Vol. 28 (4), pp. e109-e112. Date of Electronic Publication: 2022 May 20.
Typ publikacji:
Letter
MeSH Terms:
Hematuria*/diagnosis
Hematuria*/etiology
Hemophilia A*/complications
Hemophilia A*/diagnosis
Adult ; Humans
Opinia redakcyjna
Tytuł:
Anti-TFPI for hemostasis induction in patients with rare bleeding disorders, an ex vivo thrombin generation (TG) guided pilot study.
Autorzy:
Barg AA; National Hemophilia Center, Sheba Medical Center, Tel Hashomer, Israel; Amalia Biron Research Institute of Thrombosis and Hemostasis, Sackler School of Medicine, Tel Aviv University, Israel.
Brutman-Barazani T; National Hemophilia Center, Sheba Medical Center, Tel Hashomer, Israel; Amalia Biron Research Institute of Thrombosis and Hemostasis, Sackler School of Medicine, Tel Aviv University, Israel.
Avishai E; National Hemophilia Center, Sheba Medical Center, Tel Hashomer, Israel; Amalia Biron Research Institute of Thrombosis and Hemostasis, Sackler School of Medicine, Tel Aviv University, Israel.
Budnik I; Department of Pathophysiology, Sechenov First Moscow State Medical University (Sechenov University), Russia.
Cohen O; National Hemophilia Center, Sheba Medical Center, Tel Hashomer, Israel; Amalia Biron Research Institute of Thrombosis and Hemostasis, Sackler School of Medicine, Tel Aviv University, Israel.
Dardik R; National Hemophilia Center, Sheba Medical Center, Tel Hashomer, Israel; Amalia Biron Research Institute of Thrombosis and Hemostasis, Sackler School of Medicine, Tel Aviv University, Israel.
Levy-Mendelovich S; National Hemophilia Center, Sheba Medical Center, Tel Hashomer, Israel; Amalia Biron Research Institute of Thrombosis and Hemostasis, Sackler School of Medicine, Tel Aviv University, Israel.
Livnat T; National Hemophilia Center, Sheba Medical Center, Tel Hashomer, Israel; Amalia Biron Research Institute of Thrombosis and Hemostasis, Sackler School of Medicine, Tel Aviv University, Israel.
Kenet G; National Hemophilia Center, Sheba Medical Center, Tel Hashomer, Israel; Amalia Biron Research Institute of Thrombosis and Hemostasis, Sackler School of Medicine, Tel Aviv University, Israel. Electronic address: .
Pokaż więcej
Źródło:
Blood cells, molecules & diseases [Blood Cells Mol Dis] 2022 Jul; Vol. 95, pp. 102663. Date of Electronic Publication: 2022 Apr 12.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hemophilia A*/complications
Hemophilia A*/drug therapy
Hemostatics*
Hemorrhage/etiology ; Hemorrhage/prevention & control ; Hemostasis ; Humans ; Lipoproteins ; Pilot Projects ; Thrombin/metabolism
Czasopismo naukowe
Tytuł:
A phase IV, multicentre, open-label study of emicizumab prophylaxis in people with haemophilia A with or without FVIII inhibitors undergoing minor surgical procedures.
Autorzy:
Escobar M; University of Texas Health Science Center, Houston, Texas, USA.
Dunn A; Nationwide Children's Hospital, Columbus, Ohio, USA.
Quon D; Orthopedic Hemophilia Treatment Center, Los Angeles, California, USA.
Trzaskoma B; Genentech, Inc., South San Francisco, California, USA.
Lee L; Genentech, Inc., South San Francisco, California, USA.
Ko RH; Genentech, Inc., South San Francisco, California, USA.
Carpenter SL; Children's Mercy Hospital, Kansas City, Missouri, USA.
Pokaż więcej
Źródło:
Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2022 Jul; Vol. 28 (4), pp. e105-e108. Date of Electronic Publication: 2022 May 05.
Typ publikacji:
Letter; Multicenter Study
MeSH Terms:
Antibodies, Bispecific*/pharmacology
Antibodies, Bispecific*/therapeutic use
Hemophilia A*/complications
Hemophilia A*/drug therapy
Antibodies, Monoclonal, Humanized/pharmacology ; Antibodies, Monoclonal, Humanized/therapeutic use ; Factor VIII/therapeutic use ; Humans ; Minor Surgical Procedures
Raport
Tytuł:
European principles of care for physiotherapy provision for persons with inherited bleeding disorders: Perspectives of physiotherapists and patients.
Autorzy:
de Kleijn P; European Haemophilia Consortium (EHC), Brussels, Belgium.
Duport G; European Haemophilia Consortium (EHC), Brussels, Belgium.; Association Française des Hémophiles (French Haemophilia Association), Paris, France.
Jansone K; European Haemophilia Consortium (EHC), Brussels, Belgium.
Marinić M; European Haemophilia Consortium (EHC), Brussels, Belgium.; Institute of Social Sciences Ivo Pilar, Zagreb, Croatia.; Društvo hemofiličara Hrvatske (Croatian Haemophilia Society), Croatia.
McLaughlin P; European Association for Haemophilia and Allied Disorders Physiotherapy Committee (EAHAD), Brussels, Belgium.; Katharine Dormandy Haemophilia Centre and Thrombosis Unit, Royal Free London NHS Foundation Trust, London, UK.
Noone D; European Haemophilia Consortium (EHC), Brussels, Belgium.
Ramishvili L; European Association for Haemophilia and Allied Disorders Physiotherapy Committee (EAHAD), Brussels, Belgium.; Haemophilia and Thrombosis Treatment Centre, K. Eristavi National Centre of Experimental and Clinical Surgery, Tbilisi, Georgia.
Tollwé A; European Haemophilia Consortium (EHC), Brussels, Belgium.; Förbundet Blödarsjuka i Sverige (Swedish Bleeding Disorder Society), Sweden.; Kent Haemophilia and Thrombosis Centre, East Kent Hospitals University NHS Trust, Canterbury, UK.
Stephensen D; European Association for Haemophilia and Allied Disorders Physiotherapy Committee (EAHAD), Brussels, Belgium.; Haemophilia Centre, Royal London Hospital, Barts Health NHS Trust, London, UK.; European Haemophilia Consortium (EHC), Committee of Women and Bleeding Disorders, Brussels, Belgium.
Pokaż więcej
Corporate Authors:
European Haemophilia Consortium and EAHAD Physiotherapy Committee
Źródło:
Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2022 Jul; Vol. 28 (4), pp. 649-655. Date of Electronic Publication: 2022 May 04.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Hemophilia A*/complications
Hemophilia A*/therapy
Physical Therapists*
von Willebrand Diseases*/complications
Female ; Hemorrhage/complications ; Humans ; Male ; Physical Therapy Modalities
Czasopismo naukowe
Tytuł:
CTLA4-Ig prevents development of neutralizing antibody formation after continuous treatment with human FVIII in HA rats.
Autorzy:
Øvlisen GO; Global Drug Discovery, Novo Nordisk A/S, Maloev, Denmark.; Department of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Frederiksberg, Denmark.
Thygesen P; Global Drug Discovery, Novo Nordisk A/S, Maloev, Denmark.
Weldingh KN; Global Discovery and Development Sciences, Maloev, Denmark.
Bloem E; Global Research Technologies, Novo Nordisk A/S, Maloev, Denmark.
Skov S; Department of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Frederiksberg, Denmark.
Almholt K; Global Drug Discovery, Novo Nordisk A/S, Maloev, Denmark.
Lövgren KM; Glostrup Research Institute, Clinical Experimental Research, Glostrup, Denmark.
Ley CD; Global Drug Discovery, Novo Nordisk A/S, Maloev, Denmark.
Holm TL; Clinical Pharmacology, Leo Pharma, Ballerup, Denmark.
Pokaż więcej
Źródło:
Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2022 Jul; Vol. 28 (4), pp. 568-577. Date of Electronic Publication: 2022 Apr 25.
Typ publikacji:
Journal Article
MeSH Terms:
Hemophilia A*/drug therapy
Hemophilia A*/prevention & control
Abatacept/pharmacology ; Abatacept/therapeutic use ; Animals ; Antibodies, Neutralizing ; Antibody Formation ; CTLA-4 Antigen ; Factor VIII ; Hemorrhage/drug therapy ; Humans ; Rats ; Recombinant Proteins/pharmacology ; Recombinant Proteins/therapeutic use
Czasopismo naukowe
Tytuł:
Efanesoctocog alfa elicits functional clot formation that is indistinguishable to that of recombinant factor VIII.
Autorzy:
Demers M; Sanofi, Waltham, Massachusetts, USA.
Aleman MM; Sanofi, Waltham, Massachusetts, USA.
Kistanova E; Sanofi, Waltham, Massachusetts, USA.
Peters R; Sanofi, Waltham, Massachusetts, USA.
Salas J; Sanofi, Waltham, Massachusetts, USA.
Seth Chhabra E; Sanofi, Waltham, Massachusetts, USA.
Pokaż więcej
Źródło:
Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2022 Jul; Vol. 20 (7), pp. 1674-1683. Date of Electronic Publication: 2022 May 22.
Typ publikacji:
Journal Article
MeSH Terms:
Hemophilia A*
Hemostatics*/therapeutic use
Animals ; Factor VIII/metabolism ; Fibrin ; Humans ; Mice ; Tissue Plasminogen Activator/therapeutic use ; von Willebrand Factor/metabolism
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

Prześlij opinię

Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

Formularz